# EDGAR Filing Document

**Accession Number:** 0000890821
**File Stem:** 0001493152-25-026563
**Filing Date:** 2025-12
**Character Count:** 2494
**Document Hash:** d5135b30efbd19dca8d3686b8a30fa75
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-026563.hdr.sgml**: 20260320

**ACCESSION NUMBER**: 0001493152-25-026563

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251208

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Enveric Biosciences, Inc.
- **CENTRAL INDEX KEY:** 0000890821
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 954484725
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 245 FIRST STREET RIVERVIEW II 18TH FLOOR
- **CITY:** CAMBRIDGE
- **STATE:** MA
- **ZIP:** 02142
- **BUSINESS PHONE:** (617) 444-8400

**MAIL ADDRESS:**
- **STREET 1:** 245 FIRST STREET RIVERVIEW II 18TH FLOOR
- **CITY:** CAMBRIDGE
- **STATE:** MA
- **ZIP:** 02142

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AMERI Holdings, Inc.
- **DATE OF NAME CHANGE:** 20150527

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SPATIALIZER AUDIO LABORATORIES INC
- **DATE OF NAME CHANGE:** 19950323

December 8, 2025

*<u>VIA EDGAR</u>*

United States Securities and Exchange Commission<br> Division of Corporation Finance<br> 100 F Street, N.E.<br> Washington, D.C. 20549<br>

---

| | |
|:---|:---|
| RE: | Enveric Biosciences, Inc. |
|  | Registration Statement on Form S-3, as amended |
|  | <u>(File No. 333-290580)</u> |
|  | Acceleration Request |
|  | Requested Date: December 8, 2025 |
|  | Requested Time: 4:30 p.m., Eastern Time |

---

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended (the "Securities Act"), Enveric Biosciences, Inc. (the "Company") requests that the above-referenced Registration Statement (the "Registration Statement") be declared effective by the Securities and Exchange Commission (the "Commission") at the "Requested Date" and "Requested Time" set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Commission.

Please call Adin J. Tarr of Greenberg Traurig, LLP at (602) 445-8058 to confirm the effectiveness of the Registration Statement or with any questions.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| Enveric Biosciences, Inc. | Enveric Biosciences, Inc. |
| By: | */s/ Joseph Tucker* |
| Name: | Joseph Tucker, Ph.D. |
| Title: | Chief Executive Officer |

---